| 期刊全稱(chēng) | Atrial Fibrillation Therapy | | 影響因子2023 | Gheorghe-Andrei Dan,Antoni Bayés de Luna,John Camm | | 視頻video | http://file.papertrans.cn/165/164855/164855.mp4 | | 發(fā)行地址 | Discusses new diagnostic tools for best selecting AF patients for specific therapies.Presents recent research in a highly practical, easy reference style.Emphasis is on a just-the-facts approach to th | | 學(xué)科分類(lèi) | Current Cardiovascular Therapy | | 圖書(shū)封面 |  | | 影響因子 | .The paradigm for atrial fibrillation (AF) management has changed significantly in recent years. A new era has begun for the prevention of one of the most tremendous complication of AF, stroke. Prevention of ischemic stroke in AF patients with oral anticoagulants represents a huge challenge because of the narrow therapeutic change of these drugs, interindividual and intraindividual variability, and the unsatisfactory time in therapeutically range (TTR) with this type of medication..New guidelines have emerged as a result of new mechanisms for initiation and perpetuation for pharmacotherapy to cure AF and trials with new classes of antithrombotic drugs are ongoing. The treatment of AF is still in its infancy, but recent research is revealing how it can be applied with optimal efficacy. This book assists trainees, recertifying physicians, practicing physicians and other professional staff in internal medicine, cardiology, emergency medicine, and clinical pharmacology to apply new diagnostic tools for selecting the best treatment options for AF patients.. | | Pindex | Book 2014 |
The information of publication is updating
|
|
|Archiver|手機(jī)版|小黑屋|
派博傳思國(guó)際
( 京公網(wǎng)安備110108008328)
GMT+8, 2025-10-7 20:44
發(fā)表于 2025-3-21 17:40:36
